A. Serrano

发表

Rexpression of HLA class I antigens and restoration of antigen‐specific CTL response in melanoma cells following 5‐aza‐2′‐deoxycytidine treatment

F. Garrido, F. Ruiz-Cabello, R. Méndez, 2001, International journal of cancer.

LAGE‐1, a new gene with tumor specificity

L. Michaux, T. Boon, E. De Plaen, 1998, International journal of cancer.

Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma.

F. Brasseur, P. Bruggen, T. Boon, 1999, Journal of immunology.

Differential expression of MHC class II genes in lung tumour cell lines.

A. Concha, F. Garrido, F. Ruiz-Cabello, 1998, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Dendritic cell immunizations alone or combined with low doses of interleukin‐2 induce specific immune responses in melanoma patients

A. Aguirre, A. Escobar, F. Salazar-Onfray, 2005, Clinical and experimental immunology.

Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker

O. Larsson, R. Kiessling, A. Aguirre, 2002, British Journal of Cancer.

Quantitative evaluation of the expression of MAGE genes in tumors by limiting dilution of cDNA libraries

F. Brasseur, T. Boon, D. Rimoldi, 1999, International journal of cancer.

Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression

A. Concha, F. Garrido, L. Real, 2000, Cancer Immunology, Immunotherapy.

Analysis of HLA class I expression in different metastases from two melanoma patients undergoing peptide immunotherapy.

F. Garrido, F. Ruiz-Cabello, E. Jäger, 2001, Tissue antigens.

Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors

F. Garrido, L. Real, P. Jiménez, 1999, International journal of cancer.

Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient

J. Zeuthen, F. Garrido, L. Real, 2001, Cancer Immunology, Immunotherapy.

Melanoma on a Human MAGE-A 10 Antigen Encoded by Cytolytic T Lymphocytes Recognize

F. Brasseur, A. Serrano, 1999 .

Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line.

F. Real, G. Berrozpe, F. Garrido, 1996, Tissue antigens.

Differential MAGE-1 gene expression in two variants of an erythroleukemic cell line (K562).

F. Garrido, F. Ruiz-Cabello, A. Serrano, 1995, Immunobiology.

Differential effect on U937 cell differentiation by targeting transcriptional factors implicated in tissue- or stage-specific induced integrin expression.

F. Garrido, L. Real, P. Jiménez, 1999, Experimental hematology.

Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis.

M. Redondo, M. Morell, E. Perea-Millá, 2003, Human pathology.

Methylated CpG points identified within MAGE‐1 promoter are involved in gene repression

F. Garrido, F. Ruiz-Cabello, A. Serrano, 1996, International journal of cancer.

Characterization of a gastric tumor cell line defective in MHC class I inducibility by both alpha- and gamma-interferon.

F. Garrido, F. Ruiz-Cabello, T. Cabrera, 1996, Tissue Antigens.

Role of Gene Methylation in Antitumor Immune Response: Implication for Tumor Progression

M. Redondo, A. Serrano, Isabel Castro-Vega, 2011, Cancers.

Characterization of a gastric tumor cell line defective in MHC class I inducibility by both α- and γ-interferon

F. Garrido, F. Ruiz-Cabello, T. Cabrera, 1996 .

EXPRESSION OF HLA CLASS I ANTIGENS AND RESTORATION OF ANTIGEN-SPECIFIC CTL RESPONSE IN MELANOMA CELLS FOLLOWING 5-AZA-2 9-DEOXYCYTIDINE TREATMENT

F. Garrido, F. Ruiz-Cabello, R. Méndez, 2001 .

Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell line

F. Garrido, L. Real, P. Jiménez, 1998, Cancer Immunology, Immunotherapy.

Regulation of Clusterin Expression in Human Cancer via DNA Methylation

M. Redondo, A. Rueda, A. Serrano, 2009, Tumor Biology.

Regulation of Clusterin Gene Expression.

M. Redondo, M. García-Aranda, A. Serrano, 2018, Current protein & peptide science.

Downregulation of clusterin mediates sensitivity to protein kinase inhibitors in breast cancer cells

M. Redondo, M. García-Aranda, A. Serrano, 2015, Anti-cancer drugs.

A mutation determining the loss of HLA-A2 antigen expression in a cervical carcinoma reveals novel splicing of human MHC class I classical transcripts in both tumoral and normal cells

P. Stern, F. Garrido, P. Jiménez, 2000, Immunogenetics.

Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicity

M. Gleave, M. Redondo, M. Morell, 2007, Breast Cancer Research.

Differential expression of MHC class II genes in lung tumour cell lines.

F. Ruiz-Cabello, M. Morell, A. Serrano, 1998, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.